Pfizer and Moderna, forced to expand their clinical studies on the effects of their childhood vaccines against COVID-19 in the United States
The New York Times publishes that the United States Food and Drug Administration (FDA) requires this of both companies, whose vaccines do not appear to be approved until 2022.
